NINDS Launches Parkinson's Disease Biomarkers Program with New Grants | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The National Institute of Neurological Disorders and Stroke has launched a new program that aims to spur development of biomarkers for use in battling Parkinson's disease and plans to use $5 million this year to fund such projects.

In addition to developing new biomarkers, the $5 million this year will go toward the development of new discovery tools and testing them.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.